Verteporfin Therapy of Subfoveal Occult Choroidal Neovascularization in AMD Using Delayed Light Application: One-year Results of the VALIO Study

American Journal of Ophthalmology

Volumn 144, Issue 6, 2007, Pages

  Rosenfeld, Philip J ^a   Boyer, David S ^b   Bressler, Neil M ^c   Fish, Gary ^d   Grizzard, W Sanderson ^e   Hao, Yong ^f   Hnik, Peter ^f   Hudson, Henry L ^g   Singerman, Lawrence ^h   Slakter, Jason S ⁱ  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b RETINA VITREOUS ASSOCIATES MEDICAL GROUP   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d TEXAS RETINA ASSOCIATES   (United States)

^e Retina Associates of Florida   (United States)

^f QLT Inc   (United States)

^g Retina Centers PC   (United States)

^h Cleveland Inc   (United States)

ⁱ EAR AND THROAT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

ADULT; ARTICLE; BACKACHE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EYE PAIN; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; INJECTION SITE EXTRAVASATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA HEMORRHAGE; RETINA MACULA AGE RELATED DEGENERATION; RETREATMENT; SIDE EFFECT; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VISION; VISUAL ACUITY;

EID: 36249019912     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2007.08.017     Document Type: Article

References (4)

1. Verteporfin In Photodynamic Therapy (VIP) Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-Verteporfin In Photodynamic Therapy Report no. 2. Am J Ophthalmol 131 (2001) 541-560
2. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) and Verteporfin In Photodynamic Therapy (VIP) Study Groups. Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration-TAP and VIP Report no. 1. Am J Ophthalmol 136 (2003) 407-418
3. Miller J.W., Schmidt-Erfurth U., Sickenberg M., et al. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study. Arch Ophthalmol 117 (1999) 1161-1173
4. Schmidt-Erfurth U., Miller J.W., Sickenberg M., et al. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study. Arch Ophthalmol 117 (1999) 1177-1187